In corneal graft rejection, rapid reversal of the rejection process is necessary to mini mise endothelial cell loss. Ten consecutive patients with acute endothelial rejection were treated with a single 500 mg pulse of methylprednisolone intravenously and topical prednisolone 1% drops hourly. The rejection episode was successfully reversed in eight (80%) of the 10 grafts . This preliminary ti-ial indicates that cortico steroid pulse therapy may be beneficial in the management of severe corneal graft rejection with the advantage of avoiding prolonged oral corticosteroid therapy. reported that 17 of 23 grafts (73.9%) that developed a single episode of endothelial rejection failed when only topical cortico steroids were used. Our poor results using topical corticosteroids alone led us to modify our treatment regimen for cases of definite
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Patients and Methods
Ten consecutive adult patients presenting with endothelial rejection were entered into the trial; all gave informed consent prior to participation. Endothelial rejection was diag nosed when an eye with a previously clear, Table I ; five males and 5 females were included in the study, with a mean age of 51.4 years (range 18-68). Of the six patients who had had previous grafts, two had had three grafts and one patient four previous grafts.
Seven patients had vascularisation of the host cornea prior to grafting. The interval from the onset of rejection to treatment ranged from four days to three weeks. Three patients had a definite endothelial rejection line and the remaininR 7 had diffuse endothelial rejection. 
Results
In eight (80%) of the 10 grafts the rejection episode reversed and the graft became clear. The total white cell count rose during the first two to three days: this was predominantly the result of an increased number of neu trophils. The lymphocyte count was decreased on the day following therapy but this had recovered by the second day (Fig. 1) .
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